The human blue opsin promoter directs transgene expression in short-wave cones and bipolar cells in the mouse retina.
J Chen(California Institute of Technology), Emil Bogenmann(California Institute of Technology), Athos Gianella-Borradori(Servier (France)), Ágoston Szél(Semmelweis University), B.J. Woodford(California Institute of Technology), Janis Lem(Massachusetts Eye and Ear Infirmary), Melvin I. Simon(California Institute of Technology), Chandra L. Tucker(University of Colorado Denver)
Cited by 54
Related Papers
Magnetite biomineralization in the human brain.
|Proceedings of the National Academy of Sciences|1992|616
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
|The Lancet Neurology|2020|495
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|358
The DEP Domain Determines Subcellular Targeting of the GTPase Activating Protein RGS9<i>In Vivo</i>
|Journal of Neuroscience|2003|120